Physician profile
David Heimburger
NPI 1437172608
$1,106.56
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.73 · 2021: $32.96 · 2022: $25.86 · 2023: $915 · 2024: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $893 · Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $892.65 |
| Food and Beverage | $135.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $892.65 | 2023 | Illuccix |
| Teleflex LLC | $97.82 | 2024 | |
| Palette Life Sciences, INC. | $47.79 | 2022-2023 | |
| Boston Scientific Corporation | $32.96 | 2021 | |
| Bsn Medical INC | $19.73 | 2020 | |
| Bioprotect Medical, INC. | $15.61 | 2024 | Bioprotect Balloon Implant System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Heimburger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.